Recurrent Glioblastoma: What Is the Route?

Affiliations

Editorial

Alberto Bosio et al. Cancers (Basel). 2023.

. 2023 Mar 29;15(7):2028.

doi: 10.3390/cancers15072028.

¹ Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, via Gattamelata 64, 35128 Padua, Italy.

Abstract

Glioblastoma (GBM) is the most frequent and aggressive malignant primary central nervous system tumor in adults [...].

The authors declare no conflict of interest.

1. Capo G., Skrap M., Guarracino I., Isola M., Battistella C., Ius T., Tomasino B. Cognitive Functions in Repeated Glioma Surgery. Cancers. 2020;12:1077. doi: 10.3390/cancers12051077. - DOI - PMC - PubMed
1. Lietke S., Schmutzer M., Schwartz C., Weller J., Siller S., Aumiller M., Heckl C., Forbrig R., Niyazi M., Egensperger R., et al. Interstitial Photodynamic Therapy Using 5-ALA for Malignant Glioma Recurrences. Cancers. 2021;13:1767. doi: 10.3390/cancers13081767. - DOI - PMC - PubMed
1. Birzu C., French P., Caccese M., Cerretti G., Idbaih A., Zagonel V., Lombardi G. Recurrent Glioblastoma: From Molecular Landscape to New Treatment Perspectives. Cancers. 2020;13:E47. doi: 10.3390/cancers13010047. - DOI - PMC - PubMed
1. Lombardi G., Caccese M., Padovan M., Cerretti G., Pintacuda G., Manara R., Di Sarra F., Zagonel V. Regorafenib in Recurrent Glioblastoma Patients: A Large and Monocentric Real-Life Study. Cancers. 2021;13:4731. doi: 10.3390/cancers13184731. - DOI - PMC - PubMed
1. Khurshed M., Molenaar R.J., van Linde M.E., Mathôt R.A., Struys E.A., van Wezel T., van Noorden C.J., Klümpen H.J., Bovée J.V., Wilmink J.W. A Phase Ib Clinical Trial of Metformin and Chloroquine in Patients with IDH1-Mutated Solid Tumors. Cancers. 2021;13:2474. doi: 10.3390/cancers13102474. - DOI - PMC - PubMed